We've found
						7,711
						 archived clinical trials in
						Depression
					
				We've found
						7,711
						 archived clinical trials in
						Depression
	
	Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety
	
Updated: 10/25/2017
  
  
  Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety
		Status: Enrolling	
	Updated: 10/25/2017
	
	Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety
	
Updated: 10/25/2017
  
  
  	  Connection to Care: Pilot Study of a Mobile Health Tool for Patients With Depression and Anxiety
		Status: Enrolling	
	Updated: 10/25/2017
Click here to add this to my saved trials
		    
			
	Increasing Physical Activity in Persons With Depression
	
Updated: 10/26/2017
  
  
  Increasing Physical Activity in Persons With Depression - Pilot
		Status: Enrolling	
	Updated: 10/26/2017
	
	Increasing Physical Activity in Persons With Depression
	
Updated: 10/26/2017
  
  
  	  Increasing Physical Activity in Persons With Depression - Pilot
		Status: Enrolling	
	Updated: 10/26/2017
Click here to add this to my saved trials
		    
			
	Treatment Outcome of Vascular Depression
	
Updated: 10/27/2017
  
  
  Treatment Outcome of Vascular Depression
		Status: Enrolling	
	Updated: 10/27/2017
	
	Treatment Outcome of Vascular Depression
	
Updated: 10/27/2017
  
  
  	  Treatment Outcome of Vascular Depression
		Status: Enrolling	
	Updated: 10/27/2017
Click here to add this to my saved trials
		    
			
	Treatment Outcome of Vascular Depression
	
Updated: 10/27/2017
  
  
  Treatment Outcome of Vascular Depression
		Status: Enrolling	
	Updated: 10/27/2017
	
	Treatment Outcome of Vascular Depression
	
Updated: 10/27/2017
  
  
  	  Treatment Outcome of Vascular Depression
		Status: Enrolling	
	Updated: 10/27/2017
Click here to add this to my saved trials
		    
			
	Predictors of Antidepressant Response
	
Updated: 10/31/2017
  
  
  Predictors of Antidepressant Response
		Status: Enrolling	
	Updated: 10/31/2017
	
	Predictors of Antidepressant Response
	
Updated: 10/31/2017
  
  
  	  Predictors of Antidepressant Response
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
	
	Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
	
Updated: 10/31/2017
  
  
  	  A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Dose Optimization Study of Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
		Status: Enrolling	
	Updated: 10/31/2017
Click here to add this to my saved trials
		    
			
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
	
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  	  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
Click here to add this to my saved trials
		    
			
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
	
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  	  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
Click here to add this to my saved trials
		    
			
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
	
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  	  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
Click here to add this to my saved trials
		    
			
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
	
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  	  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
Click here to add this to my saved trials
		    
			
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
	
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  	  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
Click here to add this to my saved trials
		    
			
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
	
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  	  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
Click here to add this to my saved trials
		    
			
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
	
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  	  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
Click here to add this to my saved trials
		    
			
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
	
	Research Evaluating the Value of Augmenting Medication With Psychotherapy
	
Updated: 11/1/2017
  
  
  	  CBASP Augmentation for Treatment of Chronic Depression
		Status: Enrolling	
	Updated: 11/1/2017
Click here to add this to my saved trials
		    
			
	Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression
	
Updated: 11/2/2017
  
  
  Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression: A 31 Phosphorus MR Spectroscopy Study
		Status: Enrolling	
	Updated: 11/2/2017
	
	Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression
	
Updated: 11/2/2017
  
  
  	  Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression: A 31 Phosphorus MR Spectroscopy Study
		Status: Enrolling	
	Updated: 11/2/2017
Click here to add this to my saved trials
		    
			
	Depression and Health Outcomes in Refractory Epilepsy
	
Updated: 11/2/2017
  
  
  Depression and Health Outcomes in Refractory Epilepsy
		Status: Enrolling	
	Updated: 11/2/2017
	
	Depression and Health Outcomes in Refractory Epilepsy
	
Updated: 11/2/2017
  
  
  	  Depression and Health Outcomes in Refractory Epilepsy
		Status: Enrolling	
	Updated: 11/2/2017
Click here to add this to my saved trials
		    
			
	Depression and Health Outcomes in Refractory Epilepsy
	
Updated: 11/2/2017
  
  
  Depression and Health Outcomes in Refractory Epilepsy
		Status: Enrolling	
	Updated: 11/2/2017
	
	Depression and Health Outcomes in Refractory Epilepsy
	
Updated: 11/2/2017
  
  
  	  Depression and Health Outcomes in Refractory Epilepsy
		Status: Enrolling	
	Updated: 11/2/2017
Click here to add this to my saved trials
		    
			
	Computerized Tailored Intervention for Behavioral Sequelae of PTSD in Veterans
	
Updated: 11/2/2017
  
  
  Computerized Tailored Intervention for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans
		Status: Enrolling	
	Updated: 11/2/2017
	
	Computerized Tailored Intervention for Behavioral Sequelae of PTSD in Veterans
	
Updated: 11/2/2017
  
  
  	  Computerized Tailored Intervention for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans
		Status: Enrolling	
	Updated: 11/2/2017
Click here to add this to my saved trials
		    
			
	Computerized Tailored Intervention for Behavioral Sequelae of PTSD in Veterans
	
Updated: 11/2/2017
  
  
  Computerized Tailored Intervention for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans
		Status: Enrolling	
	Updated: 11/2/2017
	
	Computerized Tailored Intervention for Behavioral Sequelae of PTSD in Veterans
	
Updated: 11/2/2017
  
  
  	  Computerized Tailored Intervention for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans
		Status: Enrolling	
	Updated: 11/2/2017
Click here to add this to my saved trials
		    
			
	Computerized Tailored Intervention for Behavioral Sequelae of PTSD in Veterans
	
Updated: 11/2/2017
  
  
  Computerized Tailored Intervention for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans
		Status: Enrolling	
	Updated: 11/2/2017
	
	Computerized Tailored Intervention for Behavioral Sequelae of PTSD in Veterans
	
Updated: 11/2/2017
  
  
  	  Computerized Tailored Intervention for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans
		Status: Enrolling	
	Updated: 11/2/2017
Click here to add this to my saved trials
		    
			
	Incidence of Respiratory Depression in Cesarean Section
	
Updated: 11/6/2017
  
  
  A Prospective, Observational, Double-blind (Black-Box) Study Evaluating Incidence, Severity and Predictive Factors of Respiratory Depression During Postoperative Neuraxial Opioid Analgesia in Obstetric Patients After Cesarean Delivery Using Current Standard Intermittent Postoperative Monitoring Compared to Continuous Pulse Oximetry / Capnography
		Status: Enrolling	
	Updated: 11/6/2017
	
	Incidence of Respiratory Depression in Cesarean Section
	
Updated: 11/6/2017
  
  
  	  A Prospective, Observational, Double-blind (Black-Box) Study Evaluating Incidence, Severity and Predictive Factors of Respiratory Depression During Postoperative Neuraxial Opioid Analgesia in Obstetric Patients After Cesarean Delivery Using Current Standard Intermittent Postoperative Monitoring Compared to Continuous Pulse Oximetry / Capnography
		Status: Enrolling	
	Updated: 11/6/2017
Click here to add this to my saved trials
		    
			
	Slow-wave Sleep Deprivation in Depression
	
Updated: 11/6/2017
  
  
  Slow-wave Sleep Deprivation as a Possible Treatment for Major Depressive Disorder
		Status: Enrolling	
	Updated: 11/6/2017
	
	Slow-wave Sleep Deprivation in Depression
	
Updated: 11/6/2017
  
  
  	  Slow-wave Sleep Deprivation as a Possible Treatment for Major Depressive Disorder
		Status: Enrolling	
	Updated: 11/6/2017
Click here to add this to my saved trials
		    
			
	Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
	
Updated: 11/7/2017
  
  
  Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
		Status: Enrolling	
	Updated: 11/7/2017
	
	Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
	
Updated: 11/7/2017
  
  
  	  Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
		Status: Enrolling	
	Updated: 11/7/2017
Click here to add this to my saved trials
		    
			
	Text-Message-Based Depression Prevention for High-Risk Youth in the ED
	
Updated: 11/7/2017
  
  
  Text-Message-Based Depression Prevention for High-Risk Youth in the ED
		Status: Enrolling	
	Updated: 11/7/2017
	
	Text-Message-Based Depression Prevention for High-Risk Youth in the ED
	
Updated: 11/7/2017
  
  
  	  Text-Message-Based Depression Prevention for High-Risk Youth in the ED
		Status: Enrolling	
	Updated: 11/7/2017
Click here to add this to my saved trials
		    
			
	Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.
	
Updated: 11/9/2017
  
  
  Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Underserved Hispanics and African Americans With Diabetes: A Randomized, Placebo Controlled Trial.
		Status: Enrolling	
	Updated: 11/9/2017
	
	Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.
	
Updated: 11/9/2017
  
  
  	  Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Underserved Hispanics and African Americans With Diabetes: A Randomized, Placebo Controlled Trial.
		Status: Enrolling	
	Updated: 11/9/2017
Click here to add this to my saved trials
		    
			
	Retaining Cognition While Avoiding Late-Life Depression
	
Updated: 11/10/2017
  
  
  RECALL: Retaining Cognition While Avoiding Late-Life Depression
		Status: Enrolling	
	Updated: 11/10/2017
	
	Retaining Cognition While Avoiding Late-Life Depression
	
Updated: 11/10/2017
  
  
  	  RECALL: Retaining Cognition While Avoiding Late-Life Depression
		Status: Enrolling	
	Updated: 11/10/2017
Click here to add this to my saved trials
		    
			
	Retaining Cognition While Avoiding Late-Life Depression
	
Updated: 11/10/2017
  
  
  RECALL: Retaining Cognition While Avoiding Late-Life Depression
		Status: Enrolling	
	Updated: 11/10/2017
	
	Retaining Cognition While Avoiding Late-Life Depression
	
Updated: 11/10/2017
  
  
  	  RECALL: Retaining Cognition While Avoiding Late-Life Depression
		Status: Enrolling	
	Updated: 11/10/2017
Click here to add this to my saved trials
		    
			
	Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
	
Updated: 11/13/2017
  
  
  Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
		Status: Enrolling	
	Updated: 11/13/2017
	
	Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
	
Updated: 11/13/2017
  
  
  	  Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
		Status: Enrolling	
	Updated: 11/13/2017
Click here to add this to my saved trials
		    
			
	Biosignatures of Latuda for Bipolar Depression
	
Updated: 11/13/2017
  
  
  Identification of Biosignatures for Lurasidone (Latuda) Response in Bipolar Depression
		Status: Enrolling	
	Updated: 11/13/2017
	
	Biosignatures of Latuda for Bipolar Depression
	
Updated: 11/13/2017
  
  
  	  Identification of Biosignatures for Lurasidone (Latuda) Response in Bipolar Depression
		Status: Enrolling	
	Updated: 11/13/2017
Click here to add this to my saved trials
		    
			
	Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
	
Updated: 11/14/2017
  
  
  Drug Abuse, Depression and Responses to HIV Counseling
		Status: Enrolling	
	Updated: 11/14/2017
	
	Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
	
Updated: 11/14/2017
  
  
  	  Drug Abuse, Depression and Responses to HIV Counseling
		Status: Enrolling	
	Updated: 11/14/2017
Click here to add this to my saved trials
		    
			
	Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
	
Updated: 11/14/2017
  
  
  Drug Abuse, Depression and Responses to HIV Counseling
		Status: Enrolling	
	Updated: 11/14/2017
	
	Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
	
Updated: 11/14/2017
  
  
  	  Drug Abuse, Depression and Responses to HIV Counseling
		Status: Enrolling	
	Updated: 11/14/2017
Click here to add this to my saved trials
		    
			
	Trauma Survivors Outcomes and Support Study IV
	
Updated: 11/17/2017
  
  
  Integrating Information Technology Advancements Into Early PTSD Interventions
		Status: Enrolling	
	Updated: 11/17/2017
	
	Trauma Survivors Outcomes and Support Study IV
	
Updated: 11/17/2017
  
  
  	  Integrating Information Technology Advancements Into Early PTSD Interventions
		Status: Enrolling	
	Updated: 11/17/2017
Click here to add this to my saved trials
		    
			
	A Comparative Effectiveness Trial of Optimal Patient-Centered Care
	
Updated: 11/17/2017
  
  
  A Comparative Effectiveness Trial of Optimal Patient-Centered Care for US Trauma Care Systems
		Status: Enrolling	
	Updated: 11/17/2017
	
	A Comparative Effectiveness Trial of Optimal Patient-Centered Care
	
Updated: 11/17/2017
  
  
  	  A Comparative Effectiveness Trial of Optimal Patient-Centered Care for US Trauma Care Systems
		Status: Enrolling	
	Updated: 11/17/2017
Click here to add this to my saved trials
		    
			
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
	
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  	  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
Click here to add this to my saved trials
		    
			
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
	
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  	  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
Click here to add this to my saved trials
		    
			
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
	
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  	  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
Click here to add this to my saved trials
		    
			
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
	
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  	  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
Click here to add this to my saved trials
		    
			
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
	
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  	  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
Click here to add this to my saved trials
		    
			
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
	
	Lurasidone Pediatric Bipolar Study
	
Updated: 11/20/2017
  
  
  	  A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
		Status: Enrolling	
	Updated: 11/20/2017
Click here to add this to my saved trials